Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
MRUS | Merus N.V. | Director | $120K | May 7, 2024 | ||
ACRS | Aclaris Therapeutics, Inc. | Director | $26.3K | Jun 6, 2024 | ||
ACGN | Aceragen, Inc. | Director | Aug 10, 2023 | |||
PASG | Passage BIO, Inc. | Director | May 21, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|